Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mohammadhasan Namazi"'
Autor:
MohammadHasan Namazi, Morteza Safi, Hosein Vakili, Habibollah Saadat, Esfandiar Karimi, Ramin Khameneh-Bagheri
Publikováno v:
Journal of Tehran University Heart Center, Vol 8, Iss 3 (2015)
Background: Administration of glycoprotein IIb/IIIa inhibitors is an effective adjunctive treatment strategy during primary percutaneous coronary intervention (PPCI) for ST-segment elevation myocardial infarction (STEMI). Recent data suggest that an
Externí odkaz:
https://doaj.org/article/f9ef0758b0794a919880f7569cdf6007
Autor:
Mohammadhasan Namazi, Morteza Safi, Hosein Vakili, Habibollah Saadat, Saeed Alipour, Parsa Mahjoob, Maryam Taherkhani, Shamseddin Pedari, Mehrdad Taherion, Hasan Rajabi Moghaddam, Abdolkarim Alhazifi, Masoume Vatanparast, Saeed Khaligh
Publikováno v:
Acta Medica Iranica, Vol 53, Iss 3 (2015)
Chronic total occlusion (CTO) intervention is still a challenging problem. The aim of this study is to determine factors that affect PCI results.The study was conducted on 72 patients in two centers. CTO angioplasty was done by the antegrade approach
Externí odkaz:
https://doaj.org/article/b9da61beb398420f9fa055a4b6ea0c6a
Autor:
Mohammadhasan, Namazi, Elham, Mahmoudi, Morteza, Safi, Yaser, Jenab, Hossein, Vakili, Habibollah, Saadat, Saeed, Alipour Parsa, Isa, Khaheshi, Azita Hajhossein, Talasaz, Seyed Hossein, Hosseini, Mohammadreza, Tabary, Hamidreza, Poorhosseini
Publikováno v:
Acta Bio Medica : Atenei Parmensis
Background: The coronary no-reflow phenomenon is an adverse complication of percutaneous coronary interventions (PCI) which significantly worsens the outcome and survival. In this study, we have evaluated the correlation of no-reflow phenomenon with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bb48c72810d24e8592274eeb2d043818
https://pubmed.ncbi.nlm.nih.gov/34738591
https://pubmed.ncbi.nlm.nih.gov/34738591